Cardio Flashcards

1
Q

Infections of the cardiovascular system: myocarditis, pericarditis, endocarditis

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Myocarditis

A

Inflammation of the myocardium that results in myocardial injury via cytoplasmic effect or secondary to immune system response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Myopericarditis

A

Extension of myocarditis into the pericardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical features myocarditis

A

Excessive fatigue or exercise intolerance

Chest pain

Unexplained sinus tachycardia

S3, s4, or summation gallop

Abnormal ecg and echo

New cardiomegaly on chest radiograph

Atrial or ventricular arrhymia

Partial or complete heart block, new onset bundle branch block

New onset or worsening heart failure

Acute pericarditis

Cardiogenic shock

Sudden cardiac death

Respiratoy distress/tachypnea

Hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differential diagnosis myocarditis

A

Acute MI v acute and/or chronic heart failure v. Atypical chest pain v pericarditis v cardiomyopathies v valvular disease

*not all encompassing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PE myocarditis

A

Soft s3/s4 (impaired ventricular function), new murmur (secondary to valvular insuffiency-variable), pericardial friction rub (if there is extension into pericardium)
*think systolic CHF (decreased contractility )-orthopnea, dyspnea on exertion, crackles, dyspnea, paroxysmal nocturnal dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Work up myocarditis

A

EKG

Cxr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ekg myocarditis

A

Assess for arrhythmia (sinus tachycardia most common), transient ST-T wave abnormalities. Findings nonspecific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CXR myocarditis

A

Patient is presenting with chest pain and.or symptoms of heart failure-must consider all etiologies espicially: pulmonary disease, heart failure, dissection. Assess for cardiomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Echocardiogram

A

Assessment of ventricular function and structure. Evaluation of ejection fraction, left ventricular size, wall option abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PCR

A

Detection of viral genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Labs

A

CBC (possible leukocytosis), cardiac enzymes (likely elevated secondaryocyte damage), BNP (signs and sx of heart failrue), CPK (assessing muscle damage), (ESR and CRP (acute phase reactants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

___ biopsy can aid in a definitive diagnosis

A

Endomyocardial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Complications myocarditis

A

Dilated cardiomyopathy
Myopericarditis

Sudden cardiac death (20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treat myocarditis

A

Heart failure therapy (depending on clinical presentation), therapy for arrhythmias

  • beta blocker, ACEI, diuretics are feasible options
  • avoid NSAIDS, EtOH, exercise (restricted)

Prognosis is dependent upon clinicopatholigc types of myocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Infection etiologies myocarditis

A

Coxsackie B, trypanosome cruzi, trichinella spiralis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cocksackie B (picornaviridae, enterovirus) myocarditis

A

+ SsRNA, small, naked, icosahedral

Peak incidence summer and fall

Fecal oral transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Manifestations coxsackie B

A

URI, pleurodynia (devils grip-severe intercostal pain and fever), myocarditis (most common infectious etiology), aseptic meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How get trypanosome Cruzi

A

Reduvviid, animal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Where is trypanosome cruzi

A

Southern US, Mexico, SA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is trypanosome cruzi

A

Intracellular Protozoa (hemoflagellate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Phases of chagas

A

Acute-1 month

Intermediate

Chronic-years-decades to develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diagnose trypanosome cruzi

A

Peripheral smear for trypmastigotes, xenodiagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Acute chagas

A

Chagoma, romana sign

Fever, malaise, LAD

CV-myocarditis

CNS-severe meningoencephalitis (young patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Intermediate chagas
Asymptomatic
26
Chronic chagas
CV: dilated cardiomyopathy, arrhythmias Megacolon, achlasia
27
Trichinella spiralis
Invasive nematode
28
How get trichinella spiralis
Ingestionof cysts from raw pork (boars or even horses) | Humans are dead end host
29
Trichinella in human
Larvae develop in gut->mate->larvae disseminate hematogenous lh->penetrate muscle tissue Skeletal muscle, heart brain
30
Invasive cycle trichinella spiralis
With heavy infection can be lethal
31
Symptoms trichinella spiralis
Abdominal pain, diarrhea, fever (while in small intestine) | Muscle invasion: muscle aches, other sx dictated by location of larvae invasion
32
When consider trichinella spiralis diagnosis
Periorbital edema, myositis, eosinophilis
33
Diagnostics for trichinella spiralis
Serologic (ELISA) or latex agglutination, CPK levels, muscle biopsy
34
Pericarditis
Inflammation of the pericardium
35
Infectious agents of pericarditis
Viruses, bacteria, TB (caseating pericarditis), fungi, parasites
36
Presentation pericarditis
Chest pain (sharp, often positional and pleuritic in nature, relieved by leaning forward), fever, palpations
37
DDx considerations
Acute coronary syndrome (STEMI v NSTEMI v unstable angina) v ischemic heart disease v aortic dissection v pulmonary embolism v pneumothorax c cardiac tamponade v mediastinitis v gerd v gastric/duodenal ulcer v musculoskeletal (rib fix muscle spasm, costochondritis) v psychiatric (panic attack, anxiety) v cocaine induced vasospasm
38
PE pericarditis
Friction rub upon cardiac auscultation, rapid or irregular pulse. Secondary to extensive differential considerations, complete cardiac and pulmonary exams are essential
39
Work up pericarditis
EKG CXR Echo Labs
40
EKG
Diffuse ST elevations with reciprocal depressions in leads aVR and V1 with PR depression
41
CXR
Majority of CXR with pericarditis show minimal abnormalities Exception-pericardial effusion>250 mL will cause a symmetrically enlarged cardiac silhouette. Water bottle sign
42
CXR
Pericardial effusion (visible) with water bottle sign. Notice flattening of the diaphragms to compensate for the weight of the effusion
43
Echo pericarditis
Pericardial effusion (visible) with water bottle sign . Notice flattening of the diaphragms to compensate for the weight of the effusion
44
Echo pericarditis
Assess for pericardial effusion and/or tamponade. More sensitive than a CXR
45
Labs pericarditis
Cardiac enzymes (serial), CBC with differential, ESR, CRP, blood cultures if temp over 38@
46
Complciations pericardiis
Cardiac tamponade-treated with pericardiocentesis | *counsel about activity restrictions
47
Treat pericarditis
High dose asprin TID (ibuprofen, indomethacin) and colchicine
48
What is contraindicated in pericarditis
Anticoagulants
49
Infectious agents pericarditis
Cocksackis B (serous pericarditis), mycobacterium TB (caseous pericarditis)
50
Cocksackis B
Picornaviridae, enterovirus | +SsRNA, small naked icosahedral
51
Transmission cocksackis B
Fecal oral
52
Manifestations cocksackie B
URI, pleurodynia (devils grip-severe intercostal pain and fever), myocarditis(mostcommon infectious etiology), aseptic meningitis
53
Mycobacterium tuberculosis
Acid fast (weakly G+), obligate aerobes, facultative intracellular (macrophages) AFB secondary to mycotic acid cell wall composition (highly resistant to desiccation including NaOH)
54
Virluence mycobacterium Tb
Facultative intracellular, sulfatides, cord factor, surface protein can cause a deflated hypersensitivity and cell mediated immunity reaction (utilized for PPD skin testing ) wax d
55
Stains mycobacterium BT
Acid fast (ziehl-neelsen, Kenyon)-red rods Auramine-rhodamine staining-fluorescent apple green color
56
Manifestation mycobacterium Tb
Pulmonary tuberculosis | CAN cause a caseating pericarditis through direct lymphatic of hematogenous dissemination of the bacteria
57
Infective endocarditis
Infection of the cardiac valves or endocardium that leads to development of vegetations and destruction of underlying cardiac tissues. The majority of IE cases are bacterial in nature and are further subdivided into acute v subacute presentations
58
Risk factors IE
Age>60 M>F, poor dentition, IV drug abuse, structural heart disease, congenital heart disease, valvular heart disease, provalve replacemnt, rheumatic heart disease
59
Clinical manifestion IE
Manifestation can be variable and generally dependent on the virluence of the organism involved Constitutional symptoms: onset of symptoms can be nonspecific in nature and then progress towards fever, chills, weight loss, new/worsening murmur, fatigue, arthralgias and myalgia
60
Acute IE
Rapid and life threatening progression of symptoms and cardiac damage High fever, chills, weakness, SOB, pleuritic chest pain
61
Subacute IE
Slow, indolent course Low grade fever, weight loss over time, fatigue, arthralgias/myalgia
62
Complciations IE
CHF, abscess formation, hematogenous spread, embolism, systemic immune reaction , death
63
Cardiac manifestations IE
Heart murmurs-new or worsening Acute IE-R side of heart> left side of heart (Tricuspid>aortic, espicially with s aureus involvement) Subacute IE-L side of heart> R side of heart
64
Diagnostic work up IE
Blood culture x3 (always prior to abx!!!!), CBC with diff, CMP EKG, ESR, CRP, UA (assess for hematuria Transesophageal echocardiogram, CXR
65
Major criteria for IE duke
Blood culture + with consistent microorganisms from 2 separate blood cultures At least two positive >12 hr apart or lll of the three or
66
Definite diagnosis
2 major criteria or 1 major and 3 minor criteria or 5 minor criteria
67
Treat IE
Cardiogenic shock-surgery Toxic0start empiric abx Obtain BCx first and foremost then initiate empiric ABx *vancomycin with or without gentamicin Culture and sensitivities will determine how to tailor treatment-may not be necessary to initiate empiric antibiotic therapy for subacute infective endocarditis Can be best to wait for culture and sensitivities to target specific organisms
68
Give high risk patients prophylactic before dental or respiratoy procedures
Able to take PO-amoxicillin IV-ampicillin or cefazolin or ceftriaxone Allergic to penicillin -desensitize, cephalexin, clindamycin, azithromycin
69
Common infectious agents of IE
S aureus, s epidermis, s viridans, enterococcus(D strep) HÁČEK, coxiella burnetti, brucellosis , s agalactiae0rare
70
S aureus
G+ cocci, clusters, coagulate and catalase positive, facultative anaerobes Normal flora on skin (can breach) and colonize nasopharyngeal
71
Virluence s aureus
Host cell invasion! Protein A-prevents opsonization by binding Fc or IgG Coagulate-forms fibrin clot around organism Catalase-breaks down H2O2 Hemolysis-destroy RBC Leukocydins-destroy WBC
72
Invasion of tissue and blood stream s aureus
Hyaluronic ASD-breaks down CT Staphylokinase-lyse s formed clots Lipase-breaks down fat
73
Toxin mediated manifestations
Food poisoning, scalded skin syndrome, toxic shock syndrome
74
Local manifestations of s aureus
Skin-impetigo, cellulitis, folliculitis, furuncles, carbuncles Respiratory-pneumonia
75
Systemic manifestations s aureus
Acute-endocarditis, meningitis, osteomyelitis (#1 cause in adults and children), septic arthritis
76
Thx s aureus
Will vary based off of clinical presentation. For systemic disease, vancomycin is an exceptional choice. For MSSA-nafcillin is a great stating point
77
Signs of acute endocarditis from s aureus
Fatigue, chills, fever, night sweats, dyspnea, CHF,
78
Streptococcus viridans
G_ cocci in chains, a hemolytic (green zone), catalase negative, facultative anaerobes, optochin resitstant, normal oral flora, nasopharynx, GI tract Extracellular dextran binds heart valves
79
Manifestations strep viridans
Dental caries, subacute endocarditis
80
Treat strep viridans
Penicillin
81
Staph epidermidis
Coagulate negative staph CoNS G_ coccci, clusters, coagulate negative, catalase positive, novobicin sensitive, facultative anaerobes Normals skin flora
82
Virluence staph epidermidis
Adhesion polysaccharide capsule-adherence to prosthetic devices, indwelling catheters Biofilm formation
83
Manifestations s epidermidis
Subacute endocarditis, infection bacteria in neutrophil patients (susceptible)
84
Treat staph epidermidis
Vancomycin (very antibiotic resistant)
85
Enterococcus (group D strep) | Enterococcus faecalis
Gram + cocci, catalase negative, facultative anaerobes, variable hemolytic nature (alpha or gamma) Normal human bowel
86
Virluence factor enterococcus
Extracellular dextran helps bind heart valves
87
Manifestations enterococcus
Subacute bacterial endocarditis, UTI, biliary tract infections
88
Media requirements enterococci
Can grow 40% bile AND 6.5% NaCl , blood agar
89
Treat enterococcus
Vancomycin resistant forms on the rise
90
Non enterococci group D strep
Strep Boris -associated with colonic ancer and IBD) G+ cocci in chains, catalase negative, facultative anaerobes, variable hemolytic nature (a or y)normal flora in human bowel
91
Virluence non enterococci group d strep
Extracellular dextran helps bind heart valves
92
Manifestations non enterococci
Biliary tract infections, UTI, subacute bacterial endocarditis
93
Media non enterococci
40% bile , blood agar
94
HÁČEK
Gram - group of bacilli, fastidious, suspected cause of culture negative endocarditis Part of normal flora
95
Media HACEK
Chocolate agar
96
HACEK
Haemophilus (H parainfluenza most likel to cause endocarditis) Aggregatibacter sp Cardiobacterium sp Eikenella corrodens Kinde;Lola sp
97
Manifestation HACEK
Subacute endocarditis rare
98
Recall Haemophilus sp have the ability to be grown on ____ (contains factors v and x, aka NAD and Hemin). Haemophilus sp cant grow on ___ (exception-will show stellate growth on blood agar if placed on same place as s aureus. Why? S aureus has the virluence factor hemolysis-lyse s RBC)
Chocolate agar Blood agar
99
Coxiella burnetti
G- pleomorphic, obligate intracellular, aerobic, zoonotic, aerosol transmission
100
Symptoms coxiella burnetti
Q fever is a flu like sickness caused by the germ coxiella burnetti. Goats, sheep, cows and other animals carry it It is inside cell Animals spread the germ when they give birth. People who help animals give birth such as farmers and vets have higher chance of getting Q fever Wind can carry barnyard dust mixed with Q fever germs for miles. You may get sick when breath it in even if not near animals
101
Cardiac rhythm disturbances (atrial, junctional, ventricular)
Ok
102
Principles
Treat patient no ECG Establish urgency of treatment and treat reversible causes Access hemodynamically stability (LOC< BP< HR) Antiarrhythmic/electrical therapy
103
Arrhythmias
Symptoms, palpitations-skin, pounds, irregular Lightheadness-faint-like Syncope (near syncope), chest pain, dyspnea, sudden death
104
Etiology arrhythmias
Stress Ischemia (CAD), MI, HF Hypoxia , PE, COPD Metabolic acidosis Infection-endocarditis, RF Inflammation-myocarditis, pericarditis Cardiomyopathy/alcohol’ chemo Electrolytic imbalance 9low, k mg ca) Drugs -caffeine, nicotine, thyroid, aminophylline, otc, cocaine, HTN
105
Sinus tachycardia
Physiologic/pathological process Look for the cause Emotion, anxiety, fear, drugs, hyperthyroid Fever, pregnancy, anemia, CHF Hypovolemia Rx-underlying cause
106
Sinus node
Normally, the dominant cardiac pacemaker bc ofits intrinsic discharge rate is the highest of all potential cardiac pacemakers Bradycardia<60 bpm
107
Medical conditions situations associated with bradycardia
Normal ppl Healthy athlete-well trained, good endurance Physiologic component to sleep, fright, carotid sinus massage, carotid hypersensitivity, avoid tight collars, shave neck lightly, massage or ocular pressure (glaucoma), mental control-yoga training Obstructive jaundice-effect of bile salts on SAN Sliding hiatal hernia Valsava maneuver-lifting heavy objects, straining bowels Disease of the atrium or SAN-CAD(inflammation, neoplasm, cardiomyopathy, muscular dystrophy, amyloidosis) Drugs and electrolytes(digitalis, quinidine, hyperkalemia, drugs used for HTN mech is to inhibit sympathetic tone like clonidine, methyldopa, reserpine. Also beta blockers propranolol metoprolol Acute inferior MI (increased vagal tone, NV Ischemia Decrease O2, increase CO2, decrease pH, increase BP, SSS, convalescence from god toxicity
108
Causes of bradycardia
Sinus bradycardia Non conducted atrial bigeminy Sino atrial block AV block-incompete or complete - sinus rhythm with 2:1 - sinus tach with 3:1 - sinus rhythm or tach with complete block - a flutter with complete block - a fib with complete block Sinus arrhythmia-SAN forms impulses irregularly - waxes/wanes with phases of respiration - HR increase with inspiration - HR decrease with expiration - sinus arrhythmia is a normal finding
109
EKG of sinus bradycardia
P wave represents formation of sinus impulses, each atrial impulse is followed by a ventricular beat - rate <60 min - p wave of sinus origin (Norma axis) - constraint and normal PR interval (.12-.2 - constant P wave confirugation in each lead - regular or slightly irregular PP cycle or RR Yale
110
EKG SSS-tachy-Brady
EKG SB S arrest SA block -slow junctional rhythm seen in ischemic, sclerotic, inflammatory changes in SAN may cause syncope, dizziness, fatigue, heart failrue
111
Treat sinus bradycardia
Depends on clinical setting and cause -may not need to be treated Depends on hemodynamics/impaired Depends on circulation - maybe no or a few symptoms-no RX - if hemodynamically compromised may get combination of-low BP - low CO, SV, renal perfusion-oliguria - SOB, decreased cerebral profusion-confusion - CP, cool, clammy, diaphoresis - syncope, dizziness - fatigue Commonly see SB in acute inferior MI-espicially in the 1st few hours. This is related to SN ischemica or to a vagal reflex initiated int he ischemic area RX is HR <45-50 with hemodynamic compromise/unstable acute situations
112
What treat sinus bradycardia with
Atropine Epinephrine Isoproterenol Pacemaker
113
Atropine
2 mg IV for SB and repeat 10 min Use caution in glaucoma can increase IOP-narrow angle AE-urinary retention, and distention, transient
114
Epinephrine for SB
2-10 ug.min
115
Isoproterenol for SB
1 mg in 500 cc D5Q-1-4 ug/min IV
116
What is automaticity
Idk
117
Atrial arrhythmias
Premature atrial contraction (PAC) also APC Seen in absence of significant heart disease; associated with stress, alcohol, tobacco, coffee, COPD, and CAD
118
Premature beat of atrial arrhythmia
An irritable focus spontaneously fires a single stimulus - premature atrial beat - premature junctional beat - premature ventricular beat
119
SA node resets in step with __
Premature atrial beat
120
Premature atrial beat with aberrant ventricular conduction
Wide QRS
121
Non conducted premature atrial beat
No QRS
122
PAC
A single complex occurs earlier than the next expected sinus complex After the PAC, sinus rhythm usually resumes
123
Rhythm PAC
Irregular
124
P wave PAC
Present, may have different shape
125
normal in PAC
PR -varies or normaland WRS
126
Clinical PAC
In patients with heart disease, frequent PAC ma precede paroxysmal supraventricular tachycardia, a fib or a flutter
127
Treat PAC
If symptomatic - reverse causes - beta adrenergic antagonist (BB) - metoprolol 25-50mg BID-TID
128
Paroxysmal atrial tachycardia
Sudden heart rate greater than 100 | -rate irritable focus P wave
129
PAT with block (AV block)
Greater than one P/QRS complex; 2 p waves for each QRS Suspect digitalis toxicity Rapid rate, spiked P waves 2:1 ratio of P: QRS
130
Multifocal atrial tachycardia
3 or more different p waves PR interval varies Irregular ventricular rhythm Atrial rate>100 Associated with lung disease (COPD, pneumonia, ventilator, theophylline, beta agonist, electrolyte abnormalities (decreased K, decrease MG( digitalis toxicity, sepsis Irregular rhythm -P wave shape varies, atrial rate excessds 100, irregular ventricular rhythm
131
Mat treat
DC theophylline IV MG SO4 2 grams in 50 cc saline over 1 min, then 6 grams in 500 cc saline 6 hours IV verampamil
132
Treat MAT-focus on underlying cause
CCD-nondihydropyridine-to control vent rate and dec. ectopic atrial impulses Dilitazem 20 mg IV then 5-15 mg/hr drip Verampamil 2-10 mg IV (avoid if EF<40%) MgSO4 2 grams IV over 1 min, then 1-2 grams/hr, amiodarone.adenosine. Cautions ith bb (pulmonary problems). Digitalis isn’t helpful and DC cardioversion isn’t effective
133
ECG a fib
Atrial rate>350-600/min -multiple foci discharging rapidly Undulating baseline No p wave Irregular RR interval Irregularly irregular ventricular rhythm Irregular continuous chaotic atrial spikes Irregular ventricular rhythm
134
Atrial flutter
Saw tooth appearance Leads II, III, AVF< V often best leads 250-350/min
135
Identifying a flutter may require
Inverting the tracing Or employing a vagal maneuver
136
Junctional (nodal) rhythma
Paroxysmal junctional tachycardia 150-250 /min P wave may be lost , inverted before or after each QRD Sudden, irritable junctional focus paces rapidly
137
Junctional foci inherent rate
40-60 min
138
Premature ventricular contractions (PVC VPC) etiology
Normal heart CAD, MI, HF, myocardial ischemia, hypoxia Valvular heart disease, congenital heart disease Cardiomyopathy, electrolyte abnormalities Acid base imbalance Hyperthyroid Drugs
139
Premature ventricular contractions ECG
Premature, wide, bizarre QRS No preceding p wave; may produce a retrograde o wave in ST segment ST-T wave moves in opposite direction of QRS Usually full compensatory
140
Principles of treatment ventricular rhythm disturbances: causes
Consider the setting -normal, stress, hypoxia Drugs -nicotine , caffeine, thyroid, aminophylline, digitalis, intonation Heart failure Acute MI Ischemic hear disease Cardiomyopathy Electrolyte disorder -hypokalemia, hyperkalemia, hypomagnesemia
141
Treat PVC
If stable no RX: if symptomatic or in setting of ACS-metoprolol 2.5-10 mg IV If unstable-amiodarone, lidocaine (1-1.5 mg/kg up to 3 mg/kg), procainamide
142
Ventricular tachycardia
3 or more consecutive bizarre QRS complexes Ventricular rate 120-200 (100-250) Usually regular, wide QRS (>.12 sec) P wave often lost; if seen no relationship to QRS (AV dissociation) Lasts longer than 30 seconds (sustained) Fusion beats (dressler) Capture beats
143
V fibrillation
Disorganized depolarization Not effective pump Clinical setting-AMI, HF< K disturbance (low or high)
144
V flutter
250-350 per minute Sine waves Leads to v fib
145
Torsades de pointes
Twisting of the points QRS swings from positive to negative direction May be inherited (prolonged QT) or acquired (class I, II, antiarrhythmatias, alchol, TCA, electrolyte imbalance-K, Ca, Mg)
146
Treat tdp
MgSO4, 1-2 grams IV bolus Overdrive pacing Isoproternol
147
Electrolyte disturbances (K, Ca, Mg)
Altered milieu
148
K disturbance
Low; lowers resting membrane potential Enhances automaticity High; raises resting membrane potential, slows conduction, widens QRS
149
Calcium disturbances
Low; prolongs QT (torsades) High: shortens QT Acidosis Reduces threshold for VF Sensitized myocardium to re entrainment arrhythmias
150
Hypokalemia
Very common in hospital or office From diuretics, metabolic alkalosis (transcellular shift of K into cell), high aldosterone (conns Cushing), beta agonist overdose, diarrhea, renal loss
151
ECG hypokalemia
U waves, inc QT interval, flat or inverted T wave
152
Hyperkalemia etiology
Renal failure (insuffiency), metabolic acidosis, DKA, cell breakdown (hemolysis, rhamdomyolysis) ECG -peaked T wave, wide QRS, inc PR interval, loss of P wave
153
Hypocalcemia
Chronic renal failure, vitamin D defiency, hypoparathyroidism, acute pancreatitis, hypomagnesium ECG-prolongation of QT interval (QTc corrected for rate)
154
Hypercalcemia
Hyperparathyroidism, malignancy, granulomatous disorders (TB sarcoidosis), endocrine disorders (adrenal insuffiency, hyperthyroid) ECG-short QT, short ST
155
HypoMg
Poor nutrition, alcoholism, dec absorption, renal magnesium loss, diuretics ECG-long Pr, wide QRS, long QT, dec T wave
156
Hypermg
Renal failure, magnesia containing drugs
157
Hyperkalemia
Mild to moderate (K 5-7) Tall, symmetrically peaked T waves with a narrow base More severe (K=8-11 ) QRS widens, PR segment prolongs , P waves disappears; ECG resembles a sine wave in severe cases
158
Hypokalemia
ST depression T flattening
159
Hypercalcemia
Shortened QT interval due to a shortened st segment
160
Hypocalcemia
Prolonged QT interval due to a prolonged ST segment. T wave duration normal
161
Digitalis
ST depression T wave flattening on inversion Shortened QT interval, increased U wave amplitude
162
Quinidine -procainamide Disopyramide Phenothiazines Tricyclic antidepressants
Long QT , mainly due to prolonged T wave duration With flattening or inversion QRS prolongation Increased U wave amplitude Diffuse, wide, deeply inverted T waves with prolonged QT
163
Hypothermia
Temp <35 C Slow heart rate (bradycardia) J wave (Osborne wave) J point elevationwith a characteristic of an early ST segment. Slow rhythm, baseline artifact due to shivering often present
164
Pulmonary embolus
Sudden dyspnea+clear lung+x ray=PE Tachycardia Nonspecific ST-T changes ECG- S1, Q3, T3 T wave inversion V1-V4 Transient RBBB
165
Cerebral hemorrhage
Impressive ST T changes
166
Hypothyroidism
Whenever you see widespread flattening or mild inversion of T waves without associated ST segment displacement, always think of hypothyroidism about 50% of the time, the hunch will be correct Other most constant ECG finding in myxedema is low voltage of the QRS complex. Sinus bradycardia, though often mentioned is less often seen
167
Wolf parkinson
Short PR interval Slurred upstroke (delta wave) of QRS complex Accessory AV conduction pathway (bundle of Kent)
168
Valvular heart disease Dr. Khalid
Ok Recognize the etiologies, of valvular heart disease Discuss auscultation findings associated with VHD Discuss the valvular causes of systolic, diastolic and continuous murmurs
169
Valvular heart disease
20 million in USA Age dependent 3-6% of those>65 ``` Symptoms -dyspnea on exertion (most common) -angina -syncope -palpitations Fatigue, edema, ascites ```
170
Most common conditions encountered today
Degenerative (calcification) Myxomatosis degeneration (MVP) Congenital (bicuspid aortic valve) Decline in incidence of rheumatic valvular disease*huge decline just in immigrant or visitors
171
Valves affect by pressure or volume overload. Or by disease process. Like what..often multiple valves
Heart failur, endocarditis, rheumatic fever
172
Stenosis
Impedes forward flow Stenosis, sclerosis, fibrosis, calcification Leads to pressure overload; hypertrophy and heart failure As and MS
173
Regurgitation
Failure to close adequately (leaks) Reversal of flow Insufficiency, incompetitence Leas to volume overload; dilates AI and MR
174
Types of VHD
Congenital Acquired/calcification of mitral annulus Valvular dysfunction depends on tempo of disease onset (acute/chronic *** how disease presents atria size?) Example: IE-aortic cusp destruction; acute AI Example: RHD complications develop over years; compensatory mechanism
175
Rheumatic heart disease
Due to RH Females 4:1 Caused by group A strep infection (pharyngitis) virtually only cause of acquired MS(can be congenital)
176
Jones criteria
Rheumatic Example: myocarditis, pericarditis Carditis-inflammation of heart muscle 1. fever 2. arthralgia 3. increased seed rate of CRP 4. Leukocytosis 5. Prolonged PR internal 6. Elevated ASO titer
177
Symptoms RHD
Migratory olyarthritis (large joints like knees hips) Subcutaneous nodules-painless , over bone and tendon Sydenham’s chorea (st virus dance)-rapid purposeless movement of face and arms Arythema marginatum
178
Diagnose RHD (CRP not specific for inflammation lots have)
Two major criteria or one major and two minor criteria Minor 1. Fever, arthralgia, increased seed rate or CRP, leukocytosis, ECG prolonged PR, elevated ASO or antiDNASEb Major . Carditis, migratory polyarthritis, subcutaneous nodules, chorea, erythema marginatum Myocarditis, pericarditis, carditis-inflammation of heart msucle????
179
Mitral stenosis
Normal MV orifice 4-6cm^2 Fusion of mitral commissures leads to narrowing; MVA of 1-1.5 cm^2 or less equals severe MS that leases to pulmonary HTN, RVF Narrowing leads to increased left AV pressure gradient ; LAE (a fib , pul vascular changes, RVH) MAC, chest radiation
180
Mitral stenosis
4th decade, fatigue associated with decreased CO DOE, cough orthopnea, PND, pulmonary edema, hemoptysis, arterial emboli, a fib PHT with RHF-edema
181
Ortner syndrome
Hoarseness d/+ compression of left recurrent laryngeal nerve
182
PE mitral stenosis
Malar rash-ruddy cheeks (pulm color-red) or blue facies(CO2 retention assoicated with PHT; vasodilation effect) Increased Lou’s S1, increase s2 (P2 if PHT is present) Opening snap after S2 (if leaflet is mobile) S2-OS interval is short if severe MS Diastolic, low pitch, decrescendo, rumbling murmur.
183
How hear mitral stenosis
Use bell Diastolic, low pitch, decrescendo, rumbling murmur. Best heard at apex with patient in left lateral decubitus position Best heard at apex Low rumble
184
Why could th patient develop progressive symptoms to RVF Malar face rash kid
Ok
185
Case: 48 yo female with fatigue, exertional dyspnea, hoarseness, orthopnea and hemoptysis. Progression of symptoms over past 3 months. Smoker x 20 years Told she has a heart murmur since adolescence. Also remembers that she had arthritis as a pre teenager PE hoarseness noted with a raspy voice. Coughed often during exam with streaks of blood in sputum Mild JVD at 45 degrees(from right ventricle, increased right heart volume) while lying down Heart irregularly irregular rhythm (MEANS A FIB), rate 90 bpm Increase S1 S2 Loud P2-pulmonary HTN Diastolic murmur Increase S1 P2 Lungs-basilar crackles (has to be left (MS aortic stenosis) heart if think lungs involved) Mild moderate peripheral edema of lower hepatomegaly
*smoker is distactor its not COPD MS ECG-a fib and left atrial enlargement
186
Mitral stenosis treat
Anticoagulation if in a fib-prevent stroke Percutaneous balloon valvuloplasty MVR (replacement) Progressive symptoms-possible RVF RVFfailure-see ascites low extremity edema
187
RVF symptoms progressive from MS
Patients get increase LA pressure, pulmonary HTN, pulmonary edema, hepatomegale, ascites, peripheral edema Blood back!
188
A fib ecg
No p wave QRS to QRS is different Irregularly irregular rhythm
189
Left atrial enlargement
Look at V1 first part in normal person is most predominate and biphasic is small If see negative portion larger than 1 small square Biphasic and f
190
Right atrial enlargement
V2 lead 2?
191
Atria hypertrophy?
Not really always dilates bc so thin
192
Vent hypertrophy and dilate
Either
193
Did diagnosis for case
MS (diastolic rumble), a fib, hoarseness, ortner syndrome, RF-arthritis A fib-left atrial enlargement cause which is secondary to MS Ortner Possible pulmonary disease from smoking
194
Look at left border of heart if see straightening
Left atrial enlargement
195
Do we anticoagulatns this patient
Yes they have a fib bc of risk of emboli
196
Treat MS
Anticoagulant if in a fib;risk emboli Percutaneous balloon valvuloplasty (mitral commissions); success rate 95% MVR (replacement) Progressive symptoms-possible RV
197
Chronic mitral regurgitation
MVP-most common etiology/myxomatous or degenerative MV | MAC (mitral annular calcification
198
Acute Mitral regurgitation
Rupture of chordal tendineae Rupture of papillary msucle Ischemic papillary muscle dysfunction-(CAD/MI: next most common cause of MR) IE; valve perforation
199
Chest x ray mitral regurgitation
Pulmonary edema
200
Acute MR
Inc. LA pressure abruptly; pulmonary edema, LVF
201
Chronic MR
Generally well compensated ECG-LAE MAC 2% pop
202
Symptoms mitral regurgitation
Asymptomatic years-> fatigue, DOE Acute; volume overload add LV dilation, LA HTN, PHT, RVF/orthopnea, PND, RHF/LHF Acute MR can present with cardiogenic shock
203
PE mitral regurgitation
Systolic murmur(blowing, holosystolic; may be mid late systolic best heard at apex, use diaphragm Radiated into left axilla Loudness of murmur correlates with severity Decreased S1 or normal; may have a systolic click if due to MVP Valsava moves click and murmur closer to S1 , murmur increases with hand grip
204
Treat mitral regurgitaiton
Vasodilator-afterload reduction (nitroprusside) Decrease resistance to flow (decrease aortic impedance and MR to improve CO) ACE inhibitors-chronic MR IABP-decreases afterload; helps to perfuse coronary arteries Surgery for acute severe MR
205
Case: 54 SOB hyperlipidemia, HTN, diabetes, comes in chest pain , oethopnea, one episode PND, hard breathing, tachycardia, irregular pulse, RR high, JVD 45% O2 84%, loud systolic murmur at apex S3 gallop
Ok
206
Loud systolic murmur at apex
Mitral regurgitation
207
S3 gallop
Heart failure
208
Differential
CAD Murmur of mitral regurgitaiton Chest pain MI Acute MI complicated by acute LVF Ischemic papilalry msucle dysfunction causing acute MR
209
What test
Ecg, MR Chest x ray Cardiac enxymes up
210
MR turbulent flow one chamber to another
Regurgitaiton
211
ECG inferior MI
ST elevation on II III AVF RCA supplies papillary muscle causing mitral regurgitaiton
212
Cardiac enzymes MI
Markers for MI Troponin T and I; more sensitive and specific than CK-MB Elevated in 4-6 hours; peak 8-12 hours Elevated for 5-7 days Creatinine phosphokinase-rise 4-8 hours; peak 24 hours. Return to normal 48-72 hours CKMB isoenzymes more specific for MI; also elevate in myocarditis, cardioversion and CKD
213
MVP
One or both mitral leaflets will prolapse into LA during systole to cause MR/redundant tissue/myxedematous degeneration: elongated chordate 7:1 female Associated with marfans/skeletal changes
214
Symptoms MVP
Asymptomatic to arrhythmias (SVT, PVC, VT), chest pain , syncope Systolic murmur; may have systolic click RX-if hyper adrenergic state (anxious, palpitations), consider beta blocker Valve repair favored over replacement
215
Case 24 yo palpitations, chest pain, murmurs ith click, hypothyroid, tachycardia, RR high, restless, high arched palate, brownish pigmented mole R side of neck, heart systolic murmur (grade 2-3/6) at apex with radiation into L axilla. (THIS IS MITRAL REGURGITATION with MVP) S2 normal Lung clear Long arms and legs High arched palate Straight back
Differential Palpitations SVT, TC, PVC< MVP R/O hyperthyroid, R/O collagen abnormalities Echo ecg, holter,TSH, free T4, CXR
216
Treat MVP and thyroid disorder | MVP with mitral regurg
B blocker for hyper state | Regulate thyroid meds
217
Aortic stenosis
Normal AoV area is 4 cm^2 Degeneration of valve (calcific or senile) most common/aging 3% persons >65 Congenital or acquired bicuspid aortic valve (BAV)/1% population; 75% develop AS/2-10% AI Rheumatic, post inflammatory scarring (radiation)
218
Pathophysiology AS
Obstruction leads to pressure overload: LVH increase LVED pressure, diastolic dysfunction, systolic heart failure Gradient across valve >40 mmHg Different pressures Severe AS if AoV>1cm^2 LV! Not in mitral stenosis
219
Symptoms AS
6th decade-exertional dyspnea, angina, syncope, heart failure (If before 60 bicuspid) Without treatment prognosis is poor Without treatment most will die within three years of developing syncope and within two years of onset of HF Die 5 years angina 3 syncope 2 CHF
220
PE AS
Narrow pulse pressure; decreased SV and systolic pressure Delayed pulses - parvis (weak, decreased amplitude due to decreased CO) - tarsus (late, delayed, dec carotid upstroke) Dec A2, SYSTOLIC MURMUR HARSH 2nd INTERCOSTAL SPACE ON RIGHT SIDE (hear bettter here bc pulmonary artery and aorta criss cross), radiated into Supra sternal notch/carotids Gallavardin phenomenon-murmur radiated to apex (like MR)
221
How see LVH on ecg
V5 v6 high Will happen in aortic stenosis
222
LVH in aortic stenosis
Ok
223
Treat AS don’t work just temporary relief
Balloon valvuloplasty-bridge therapy to TARV or surgery (surgical valve replacement is gold standard) TARC (transcatheter aortic valve replacement -for symptomatic , trileaflet AoV sclerosis with high surgical risk. No AI Surgery and TARV operative mortality 1-3%
224
60 yo male DOE, substernal discomfort related to activity. The chest discomfort is usually relieved by rest; one time he took a nitroglycerin and he obtained relief PMH HTN, hyper lipid, peripheral vascular disease, smoker HCTZ statin, circulation pill for legs, albuterol MDI, prn, dyspnea Bp up, RR high, O290%(not good) JVP. Bit raised 30 degrees, Decreased carotid upstroke bilaterally (AS) PMI 5th 6th on left side (VH) Palpable thrill and heave, loud murmur, raspy Systolic murmur 4-6 with 3nd ICS radiated into substernal notch and carotids systolic murmur (AS) Expirations wheezes-COPD smoker
Concerns-CAD, diabetes, Need-PE, ecg, echo, chest x ray Differential=AS, angina, HTN, hyperlipidemia, probable COPD Wheezes-can get from COPD of heart failure, all wheezing is not COPD can also be heart failure, but not all heart failure wheezes Tests-ekg, echo, CXR, cardiac enzymes, Echo AoV-1cm^2 (normal is 4 cm, anything 1 or below is severe AS) Diagnosis severe AS
225
Treat severe symptomatic AS
Valve replacement No med can give
226
Aortic regurgitaiton
Due to leaflet abnormalities (bicuspid AoV, IE) Due to aortic root abnormalities (marfan syndome, aortic dissection, aging, HTN)
227
What causes acute AR
IE, aortic dissection, BAV, chest trauma, balloon valvuloplasty
228
Causes of chronic AR
Syphilis, ankylosis spondylitis, ascending aortic dilation, BAV, calcfic degeneration, rheumatic, chest radiation
229
Pathophysiology regurgitation
Volume overload can increase LVEDV, LVH, left sided HF; SOB fatigue , angina
230
Symptoms aortic regurgitaiton
Depends on rapidity of onset-due to compensatory mechanism onset
231
Acute aortic regurgitaiton
IE, aortic dissection/acute pulmonary edema, cardiogenic shock
232
Chronic aortic regurgitation
Develops over time/dyspnea, orthopnea, PND, chest pain
233
PE aortic regurgitaiton
Wide pule(diastolic low systolic high) De musket sign Corrigans pulse Quince pulse Trouble sign Durozrey sign Hills sign Bisferious pulse Diastolic, decrescendo murmur 3rd ICS LSB Systolic murmur usually present, soft Austin flint murmur; can mimic MS
234
Crescendo decrescendo-AS? Blowing murmur
Ok
235
Treat aortic regurgitation
ARB-decrease afterload to decrease regurgitation volume Surgery AoVR (replace or repair ) when symptomatic or EF<50-55%
236
Cause 72 yo male ankylosis spondylotis Started over right SI pint with pain at rest, which originally improved on ambulation. Over time progressively developed thoracic kyphosis and stiffness of lumbar spine. You have not appreciated any cardiac problems when he firs became your patient Past 12 moths complained of fatigue, exertional dyspnea, two pillow orthopnea and one to two episodes of PND in the past 30 days(developing symptoms) BP high, O2 sat 90% Slight rhythmical movement of the head with the heart bears Systolic and diastolic murmur over a partially compressed peripheral artery (from wide puls pressure) Heart-grade 2/6 diastolic, blowing murmur over 2nd -3rd ICS LSB no s3 or s4 gallop S1 normal s2 dismissed(comes from aortic valve closure if regurg will be soft) Lung-decreased breast sound Kyphosis and decreased flexion, SB and extension of lumbar spine
Concern-heart failure? Progressive ankylosis sponyltois with aortic regurgitaiton Aortic regurg De mussel-head bob Durozrey-to and fro murmur over artery Echo CT of chest-why for ankylosis spondylitis and aortic regurg to look for disections want to see aortic root
237
Valvular heart disease treatment
Reserved for when symptomatic
238
Tricuspid stenosis
Associated with MS, TR, and RHD Can be associated with carcinoid, ergot agents (cabergoline)
239
Pathophysiology tricuspid stenosis
Prominent A wave in JVP ascites, hepatomegalia (may pulsate)
240
Hear tricuspid stenosis
Diastolic, low pitch, decrescendo, murmur LSB; increase with inspiration (Corvallis sign) and decrease with expiration and valsava
241
Diastolic murmur apex
MS
242
Diastolic murmur left sternal border
Tricuspid stenosis
243
Every right valve disease
Intensity increase with inspiration due to increase intrathoracic pressure, increased venous return so murmur increase on right side
244
Tricuspid regurgitation
Common, functional, asymptomatic Associated with pulmonary HTN (COPD , Cor pulmonale, RVF), RV infarction, inferior MI, pacemaker, endocarditis, congenital trauma V wave in JVP, palpable RV lift , pulsating liver Blowing holosystolic murmur LSB, 4th ICS, increase with inspiration (Corvallis sign) due to increase venous return
245
A wave JVP
Tricuspid stenosis V wave-tricuspid regurgitation during systolic
246
Pulmonary stenosis
Atresia, congenital, can cause angina, syncope,
247
Auscultation pulmonary stenosis
Systolic crescendo-decrescendo murmur, ejection click 2nd 3rd ICS, LSB/radiated toward left shoulder clavicle and increases on inspiration/RVH
248
Association pulm stenosis
TOF TGA
249
Treat pulmonary stenosis
Balloon commissural to my if pressure gradient>50mmHg
250
Cause pulmonic regurgitation
Most due to pulmonary HTN
251
Sound pulmonic regurgitaiton
Diastolic, decrescendo blowing murmur 2nd LSB Increase P2 if PHT
252
Systolic murmu
MR (MVP), TR - AS, PS - VSD
253
Autopulmonary shunts murmur
Early mid late, holosystolic/pansystolic
254
Diastolic murmur
AR, PR | -MS, TS
255
Atrial myxoma
Murmur plop
256
Continuous murmur
PDA-machinery* AV fistula ASD with high LA pressure Coarctation
257
AV blocks
Ok
258
What is an AV block
In the cardiac conduction system that causes a disruption of atrial-to-ventricular electrical conduction
259
What are the types of AV blocks and fasciculus blocks
First degree Av Second degree AV Third degree AV Fasciculus blocks (hemiblocks) Left anterior hemiblock Left posterior hemiblock
260
Primary AV block
Prolongs AV node conduction | PR interval more than .2 sec.
261
ECG 1st degree block
P wave precedes QRS complex PR interval >.2 s (>5 small boxes) Normal PR interval (.12-.2 s) Minor AV conduction defect with delay at or below AV node
262
Etiology of 1st degree AV block
Presence of atherosclerosis, HTN, diabetes enhances chances Degeneration of conduction system/fibrosis congenital heart disease CAD-ischemia Drugs-BB, CCB, digitalis, antiarrhythmias (class I and III) Endocrine-hypothyroid, hyperthyroid, adrenal insuffiency Inflammatory-RF, SLE, MCTD, myocarditis Infiltrating-amyloidosis, sarcoidosis, hemochromatosis Valvular calcification-mitral, aortic
263
How calculate regular rhythm
Count the number of large boxes between P waves (atrial rate), R waves (ventricular rate), or pacer spikes (pacemaker rate) BPM=300 divided by the number of large boxes
264
2nd degree block types
Mobitz I Mobitz II
265
Second degree av block
Progressive PR-Interval Prolongation prior to dropped QRS Grouped beats
266
Mobitz I
Progressive lengthening results from earlier arrival in relative refractory period AV conduction Implies impairment of AV conduction (AV node) Transient
267
Etiology mobitz I
All those things that cause 1st degree AV block Digitalis toxicity Ischemic events (MI inferior) Myocarditis
268
2nd degree AV block -mobitz
May be seen with inferior AMI Level of block is at level of AV node Narrow QRS complex
269
Etiology 2nd degree AV block-mobitz type II
Ischemic heart disease May be seen with acute anterior myocardial infarction Degeneration of conduction system
270
2nd degree AV block, mobitz type II mobitz
``` PR interval uniform Dropped beat (QRS) -P wave fails to conduct ``` This block occurs at level of - bundle of HIS - both bundle branches - fasciculus branches Progressive/irreversible *may be seen with anterior AMI bc block is distal to AV; worse prognosis
271
Features of high AV block
Crest of AV node blocker Junctional escape rhythm narrow QRS, adequate rate (40-55) Right coronary artery disease, diaphragmatic infarction, edema around AV node Preceded by mobitz I second degree AV
272
Low AV block
Bundle of His, bilateral bundle branch , or trifascicular Ventricular escape rhythm Wide QRS Inadequate rate (20-40) Danger of asystole or ventricular tachycardia Left anterior descending coronary artery disease, large large anteromedial infarction, or chronic degeneration of conduction system Mobitz II second degree
273
Third degree heart block (complete heart block)
P waves never related to QRS complexes Two independent rhythms -AV dissociation-no P waves conduct to the ventricle Can occur above or below Av node Above-junctional rhythm, narrow QRS (rate 40-55_ Bellow-ventricular pacemaker wide QRS (rate 20-40
274
Etiology 3rd degree heart block
Ischemic Infiltrating diseases Cardiac surgery - by pass, valve replacement - myocarditis - degenerative
275
How do you treat 3rd degree block
Pacemaker
276
What check on every ECG
PR interval - increased consistently in primary AV block - progressively increases in each series of cycles with wenckenbach - totally variable in third degree block - decreased in WPW and LGL syndromes P without QRS response - weckebach and mobitz 2 AV blocks - third AV block-independent
277
R
As impulse travels toward the electrode +
278
S
As impulse travels away from the electrode - deflection
279
In normal ventricular conduction, what is the origin of a small q wave in V5 and V6
Q wave is first downward deflection after the p wave and the first element in the QRS complex. Negative deflection of QRS complex It is the net direction of early ventricular depolarization projects toward the negative pole of the lead axis in question
280
The septum is activated from _ to _
L to R L septal surface activated .1 s before R septal surface
281
Why normal ventricular muscle activated L to R
Right wall is thinner than L wall, therefore the impulse activates the epicardium of the RV before the LV The LV pericardial surface is activated from apex to base
282
Intrinsic deflection
Time lapse from beginning of the QRS to the peak of the R wave The time that lapses from the beginning to the QRS complex to the peak of the R wave is measured horizontally Measure time when impulse reaches the pericardial surface of ventricle
283
What is intrinsic deflection for V1 and V2
V1 .02 s V2 .04 s
284
What does it mean if it takes longer for the ID to start downward,
The impulse is late in reaching the pericardial surface Late ID in: a. BBB b. Hypertrophy/dilated
285
Common features of BBB
Wide QRS complex (.12 s or greater) ST segment -T waves slope off in opposite direction to QRS
286
Which side of the septum is activated first in RBBB
Left
287
In RBBB is there an S wave in V6?
Ok
288
Sequence of ventricular activation in RBBB
After septal activation, then activation begins in LV free wall
289
RsR’ variants in V1-V2
Normal Pertussis or straight back RV diastolic volume overload WPW syndrome RVH Du henna dystrophy
290
In lead V1 why is there a small r wave morphology in RBBB
Ok
291
Sequence of ventricular activation in LBBB
Septum activated from R side, nearly same time as RV is activated Strong septal forces, therefore neg. deflection in V1 (QS) Positive deflection V6-monophonic R
292
LBB more apt to occur with
HTN Ischemia Aortic stenosis Cardiomyopathy
293
LBBB with LAD
More myocardial dysfunction More disease in conduction system Maybe higher mortality
294
LBB with RAD
Think congestive cardiomyopathy
295
Limb leads in BBB
I and AVL usually have features of V6
296
T wave in BBB
Polarity is opposite QRS direction
297
What causes secondary T wave changes T wave in BBB
Disturbance in depolrepol
298
If t wave polarity is in the same direction of the QRS complex, it is called __ t wave change, usually due to ____
Primary Ischemia
299
In LBBB which ventricle is activated first
Right
300
Hemiblock/fasciculus block
Term for blockage of one of two main divisions of left bundle branch
301
Left bundle branch
Anterior division (superior) Posterior division (inferior)
302
Hemiblocks
Left anterior hemiblock (LAH)-more common Left posterior hemiblock (LPH)
303
Etiology of LHA
Disease in conduction system Often associated with MI (left anterior descending-LAD occlusion)
304
Criteria for LAH
Left axis deviation (usually >minus 60 degrees; others> minute 45 degrees)
305
ECG LAH
Small Q in leads I and AVL Small R in leads II, III and AVF Usually normal QRS duration or slightly widened Q1S3 (Q in I and S in III)
306
Anterior hemiblock
LAD-usually associated with MI (or other heart disease Normal or slightly widened QRS Q1S3
307
Etiology of left posterior hemiblock -less common
Disease in conduction system
308
Criteria of left posterior hemiblock
RAD >120 degrees Small R in leads I and AVL Small Q in leads II, III, AVF S1Q3 (S in I and Q in III) No evidence of RVH
309
What causes atrial enlargement
Increase in volume of blood int he chamber or Increase in resistance to blood flow out of chamber Volume overload or diastolic overload-dilation Pressure overload or systolic overload-causes hypertrophy Good leads I II III V1 RA activated first LA actiavated later
310
P wave
Depolarization of atria Doesn’t exceed 3 mm Increased amplitude-hypertrophy, HTN, AV valve disease, Cor pulmonale, congenital
311
P of RAE
Tall, pointed; taller in III than in I | P-pulmonale
312
P of LAE
Wide, notched; taller in I than in III P-mitrale 2nd half of p wave negative in V1 of III
313
RAE
Associated with TV disease or pul HTN COPD , PE, MS, or MR are causes of pul HTN
314
Right atrial enlargement (RAE)
P-pulmonale peaked p wave with amplitude greater than .25 mv (2.5 mm) in leads II, III AVF and greater than .1 mv in leads V1 and V2
315
LAE
Left atrial enlargement , P mitral M signs to P wave , broad, notched P wave duration .11 sec and amplitude of terminal negatively directed portion in V1 to greater than .1 mv or 1 mm deep and .04 sec wide with slight acid of o wave
316
Causes LAE
MS MR
317
Ventricular hypertrophy (enlargement)
Ventricles dilate in response to receiving excess volume of loot during diastole and become hypertrophied INR esponse to exerting pressure in ejecting the blood during systol
318
Left ventricular hypertrophy
Most common cause is HTN. Other causes include AS, AI, hypertrophic cardiomyopathy and coarctation of aorta Wall of LV is thicker so impulse will take longer to transverse it and arrive at pericardial surface Voltage and interval of QRS complex will increase, producing deeper S waves over RV and taller R waves over LV
319
ECG pattern LVH
Fails to distinguish between concentric hypertrophy and dilated chamber; use the term ventricular enlargement. It is the total muscle mass of the ventricle that mainly determines the QRS voltage
320
Criteria for LVH
Lack sensitivity (low 40-50%) but are specific (high 90%)
321
Romhilt estes scoring system for LVH
5 LVH 4. Probable LVH 1. 3)R or S in limb lead 20 mm or more S in V1 V2 or V3 25 mm or more R in V5 V6 30 mm or more 2. (1)Any ST shift (without digitalis Typical strain STT(with digitalis) 3. (2)LAD 30 or more 4. (1)QRS interval .09 sec or more 5. (1)ID in V5-V6 .04 sec or more 6. (3) P terminal force in V1 with more than .03 sec in duration >1 mm in depth
322
Sokolow lyon criteria
R in I and S in III>25 mm R in AVL >11 R in V6>26 mm
323
Right ventricular hypertrophy cause
Cause-COPD RVOT obstruction, VSD Congenital-TOF< pulmonic stenosis, transposition of great vessels Mitral stenosis, tricuspid regurgitaiton
324
ECG RVH
R waves assume prominence in right precordal leads and deep S waves develop in left precordial leads R:S ration>1
325
Clues to RVH
RAD +90 degree or more R in V1 7 mm or more R in V1 +S in V6 10 mm or more R/S ration in V1>1 mm or more S/R ration in V6>1 or more Late intrinsicoid deflection in V1 (.03 of more) Incomplete RBBB ST-T strain pattern in II, III, AVF P pulmonale S1 S2 S3 pattern (kids)
326
Causes of dominant r waves in V1
RVH Posterior or lateral MI WPW Hypertrophic cardiomyopathy Muscular dystrophy Normal variant
327
CAD general comments
Heart disease remains the leading cause of mortality int he USA Ischemia heart disease is now the leading cause of death worldwide 1.5 million Americans currently have CAD 25% with CAD die suddenly ; no previous manifestations Atherosclerosis is underlying cause of CAD and 90% of cases of MI and most of heart failrue
328
What happens with atherosclerotic coronary arteries from plaques
Can undergo... Fissuring or erosion Triggers thrombus formation to cause ischemia to myocardium
329
Risk factors for atherosclerosis
Hyperlipidemia-high LDL, low HDL, high TG, high lipoprotein ; 1% decrease LDL decreases risk of CAD by 1-.1% increase HDL decreases risk of CAD by 2-3% -31 million have total cholesterol greater than 240 mg/dl Smoking-benefit decreases risk of being non smoker afte 10 years Diabetes mellitus-AHA/major risk factor; increased CVD risk 2-4 times/CVD risk equivalent HTN Family history of coronary heart disease, ischemic stroke or peripheral vascular disease -ethnicity increased risk in Alaska natives, American Indians and Pacific Islanders Obesity Physical inactivity (need 10-60 min med intensity 4-7 days/week Stress Sleep problems Age and gender (male>55 female >65
330
Metabolic syndrome
Insulin resistant-increased glucose HTN High TG, low HDL Hyperuricemia Hyper coagulation Obese BMI>30-central obesity Desireable : BMI 21-24 BMI=weughtx705/height
331
Angina pectoris
``` Chest discomfort (chest pain) Term angina (Latin origin; Angkor animifear of life being extinguished from the breast) ``` Most frequent expression of myocardial ischemia Chronic stable angina: is a consequence of imbalance between oxygen supply demand Low risk of plaque rupture (small lipid core and thick fibrous cap_
332
Supply angina
Decreased oxygen delivery to tissue leads to ischemia
333
Example supply angina
Coronary vasoconstriction, stenosis, platelets release serotonin and thromboxane A2
334
Demand angina
Increased myocardial oxygen requirements and workload can lead to ischemia
335
Examples of demand angina
Exercise, stress, emotion, fever, thyrotoxicosis LVH due to As Anemia (low oxygen carrying capacity)
336
Effects of ischemia
Mechanical consequences Biochemical consequences Electrical consequences
337
Mechanical consequences ischemia
Angina, is ischemia is prolonged or develop coronary occlusion, may lead to myocardial necrosis Segmental akinetic bulging (dyskinesia)
338
Biochemical consequences ischemia
Fatty acids can’t be oxidized Increased lactate production Reduced pH with metabolic acidosis
339
Electoral consequences ischemia
Inversion fo T wave Transient displacement of ST segment Depression-subendocardial -elevation-subepicardial Electrical instability instability; VT, VF
340
LAD MI
Anterior wall infarction Leads V1-V7
341
RCA MI
Inferior wall infarction (RV infarction) Leads II, III, AVF
342
Circumflex artery MI
Lateral wall Leads I, AVL
343
Posterior descending artery
Posterior wall infarction | V1-V3
344
CV causes of chest pain
Ischemic heart disease (angina , UA, ACS, MI), VHD, pericarditis, myocarditis, cardiomyopathies
345
Non cardiac cause of chest pain
Pleuritis/pneumonia/PE Pulmonary infarction, pneumothorax, GI GI disease: GERD, PUD, gallstones, esophageal motility disorder chest wall syndromes Lung cancer Aortic aneurysm
346
Non chest pain symptoms of chronic ischemic heart disease
Dyspnea, non chest locations of discomfort (((exertional or rest) Mid epigastric or abdominal Diaphoresis Excessive fatigue and weakness Dizziness and syncope
347
Anginapectoris why exercise effect it
Fixed CA stenosis/fixed O2 supply; produces ischemia bc of increased oxygen demand
348
Angina equivalent
Due to ischemia, but described as dyspnea, fatigue, faintness and gastric educations (belching) Pathogenesis-schematic causing an elevated LV filling pressure that leads to pulmonary edema-diabetic , elderly, women
349
Signs or risk factors for angina
Xanthelasma Xanthomas Diabetic skin lesion Nicotine stains Pale Absent peripheral pulses
350
Angina
Abnormal cardiac impulse (LV dyskinesia) Bruits-carotid, abdominal area, femoral Gallop -S3, S4, both Systolic murmur of MR if papillary msucle is dysfunctional; associated with inferior or inferior posterior ischemia due to right coronary artery disease
351
What can mimic angina in absence of CAD***
AS, AI, pulmonary HTN, hypertrophic cardiomyopathy, heart failure
352
Unstable angina
New or worsening chest pain Tempo has changed, more severe, prolonged, more frequent; may occur at rest , awaken from sleep. Pain lasting longer than 20 minutes Using more medication for relief Less effort to provoke symptoms No evidence of myocyte necrosis (no elevation of tropI or CK-MB). Enzymes are normal
353
Chest pain with elevation of cardiac enzymes (trop I or CK-MB) and without ST elevation is said to have a non st elevation myocardial infarction
NSTEMI
354
Both UA and NSTEMI are called NSTEMI ACS or NSTE ACS
1.2 million US hospitalized a ACS 2/3 have NSTE ACS
355
Pathology UA and NSTEMI
Most subjects with ACS have an atherosclerotic plaque rupture or erosion; platelet aggregation and thrombus leading to partial occlusion of artery
356
Stable angina ecg
Normal in 50% (resting During angina attack may have displaced st segment; most common change is ST depression (subendocardial injury ischemia) May show old MI
357
ECG unstable angina/NSTE ACS
Magnitude of st segment depression correlated with prognosis If ST segment depressed I mm or greater in 2 or more leads-almost 4x as likel yto die within 1 year If 2 mm or greater st segment depression-almost 6x likely to die within a year If St depression is 2 mm or greater in more than one region of ecg, mortality is 10 fold
358
Differential diagnosis of NSTE ACS
PE-ecg changes, elevated troponin Aortic dissection VHD (AS, AI, hypertrophic cardiomyopathy) Myocarditis-pericarditis Stress cardiomyopathy (takostubo syndrome/broken heart syndrome) deeply inverted T wave
359
Lab CAD
Cardiac enzymes-troponin I; detected in 2-4 hours in NSTEMI Increase CK-mB (3-6 hours) BNP-increase in BNP associated with increase mortality in NSTE ACS CRP-inflammatory biomarker CMP BUN, creatinine, liver panel, electrolytes, CBC, FLP
360
Diagnostic testing for atherosclerosis
Functional and/or anatomical information for CAD
361
Functional diagnostic testing for atherosclerotic CAD
Exercise ECG, single photon emission CT (SPECT, PET) Coronary flow (PET, fractional flow reserve) Wall motion abnormalities (echo, cardiac magnetic imaging CMRI)
362
Anatomical diagnostic testing for atherosclerotic CAD
Invasive angiography, coronary CT angio (CTA) | -coronary artery calcium scoring (CAC) (note, CAC doesn’t provide data on coronary luminal narrowing
363
Signs of high risk for coronary event
Positive stress test at low work load St depression greater than 5 minutes after completion of test Decrease in BP-syst fall>10 mmHg during exercise VT during exercise Reduced EF during exercise (stress echo
364
Stress testing: exercise ECG
Exercise electrocardiography (preferred if patient is suspected to have angina) Safe... only 1 death or MI per 2500 tests
365
Contradictions exercise ECG
Recent MI or acute MI, unstable arrhythmias, acute PE, aortic dissection, unstable angina, severe AS, decompensated HF, endocarditis, DVT
366
Sensitivity and specificity exercise ECG
70% and 75% specific
367
Stress echocardiography
Recommended when baseline ECG findings are abnormal or when area of myocardium is at risk with exercise or when patients can’t exercise
368
Nuclear myocardial perfusion imaging
SPECT (single photon emission computer tomography) Useful in LBBB, LVH, digitalis effect Technetium 99
369
Pharmacological stress test
Patient unable to exercise/abnormal ECG LBBB, LVH Use: vasodilator nuclear perfusion - adenosine/regadenosine/dipyridamole - vasodilators increase HR
370
When use dobutamine echocardiogram
When patient cant exercise or when area of myocardium is at risk
371
Coronary angiography
Cardiac cath Provides anatomic diagnosis of severity of CAD Percutaneous revascularization can be performed after study Exposed to radio contrast (kidney dysfunction
372
Use of coronary angiography
Gold standard for anatomic definition of CAD Patients being considered by revascularization (CABG or PCI) PCI-90% successful; stent insertion CABG-for L main disease or 3 vessel disease
373
Coronary CT angiography
Ability to quantify lesion severity can be limited by significant calcification
374
CXR
Usually normal unless history of mi, HF< VHD Cardiomegalia in HTN< VHD, cardiomyopathy, pericardial effusion
375
Treatment of patients with stable angina non pharm
Rule out and control aggravating conditions - associated noncardiac diseases - associated cardiac disease - use of drugs aggravating angina Smoking cessation Dietary counseling for body weight and lipid control Exercise prescription Treat to targets -HTN Lipids Diabetes
376
Pharm treat to prevent MI/death/reduce symptoms
Asprin Beta blocker ACEI Statins Nitro/nitrates CCB
377
Identify aggravating conditions
Obesity-weight loss consult dietitian HTN-treat to goal Hyperthyroid-meds, RAI Anemia-find cause and treat Smoking-cease Hyperlipidemia-statins Diabetes-ADA diet, oral agents, insulin
378
Pharm treatment ASA
ASA:cyclooxygenase inhibitors of platelet activation Inhibit thromboxane production Clopidogrel blockers in ADP induced platelet aggregation
379
Bb
Block binding of catecholamines to beta receptor Decrease HR, workload, contractibility, decreased BP and myocardial O2 consumption and demand, Decrease ischemia and symptoms Decrease CV mortliaty Prior MI
380
Contraindication bb
Decompensated HF, hypotension, advanced AV block
381
ACEI
Blocks conversion of A1 to A11 Decrease CV mortality Useful in diabetic (renal protection) and patients with LV systolic dysfunction
382
Nitrates
Vasodilator of vascular smooth msucle; metabolized to NO to relax smooth muscle and coronaries Relieves ischemia and angina due to vasoconstriction Decrease preload and ventricular wall stress Nitrate intolerance; need 8-12 nitrate free interval
383
What not take nitrate with
Phosphodiesterase inhibitor
384
CCB
Doesn’t decrease mortality but Vasodilators; decrease workload, O2 demand, coronary vasospasm and reduced affected non dihydropyridines (verapamil and dilitazem) Decrease HR; verampamil negative inotropy effect Ranolazine-inhibits inward Na current and decrease intracellular calcium
385
Myocardial revascularization
CABG for L main or 3 vessel CAD multivessel with LVEF<50% Decreases angina, MI, complications from revascularization procedures; improves survival PCI-1 or 2 vessel disease -stents
386
Treat prinzmetal
Relieved by nitro Dihydropyridine CCB (amlodipine)
387
Manage los risk patient
Antianginal - BB, nitro, CCB Statin Antiplatelet-ASA/clopidogrel Anticoagulant-UF heparin Cath:revascularization if appropriate
388
High risk patient (US or NSTEMI) manag
Antianginal-BB, nitro, CCB Statin-plague stabilization Restore: endothelial function Antiplatelet-ASA/clopidogrel or prasugrel or ticagrelor glycoprotein inhibitor-11b/111a Time of catheter or PCI; blocks above platelet inhibitors tha impairs fibrinogen binding and inhibits platelet aggregation Anticoagulant-UFH or enoxaparin or bivalirudin or fondaparinux Cath: revascularization if appropriate
389
Hyperlipidemia adult treatment panel (NCEP guideline III stricter target lipid levels)
For all patients with proper events, a CHD risk equivalent or a 10 year risk of 20% or greater the goals are: LDLc less than 70mg/dl HDLc greater than 60. If less than 40 do lipid analysis TG high is 120 mg/dl Total chol less than 200 mg/dl-A1% decrease in TC yields a 3% decrease in risk of CAD
390
Statins for hyperlipidemia
``` ASA Nitrates B blocker ACE Ranexa inhibit late phase of inward Na current during repolarization; decrease angina occurrence ```
391
Diet for CAD/angina to protect against atherosclerosis
Reduce calories with goal of ideal BMI Low saturated fat Low cholesterol High fibers Fish oil or fish Antioxidants-vit c 2 g na and reduce alcohol
392
Shock
Tissue hypo perfusion and cellular hypoxia caused by Decreased O2 Decreased O2 utilization Increase O2 consumption Hypotension <80-90mmHg systolic Decrease systolic BP 40 mmHg below baseline MAP <60-65 mmHg
393
Pathophysiology shock
Failure to deliver and utilize O2-anaerobic metabolism Increase O2 consumption (tissue demand) also anaerobic metabolism Anaerobic glycolysis leads to lactate Non compensatory response-pathologic results Vasodilators shock-unregulated NOS, interstitial fluid, cellular edema, impaired O2 diffusion, increase lactate->acidosis accompanies shock Lactate levels are reflection of tissue hypoxia If Do2 (systemic O2 delivery) failrue to meet O3 demand, develop O2 debt. Cellular inflammation and injury; irreversible/decompensated shock
394
Skinextremities shock
Cool, clammy, cyanosis, mottled distally, decrease perfusion/vasoconstriction, dry mucous membranes, decrease skin turgor-seen in hypovolemia, cardiogenic, obstructive shock Warm and pink-associated with vasodilation of distributive/dissociative shock (cyanide poisoning)
395
Neck veins shock
Distended (HF, PE, tamponade) Flare (hypovolemia)
396
HR shock
Fast (sensitive indicator of shock); occasionally LO
397
BP shock
Systolic low diastolic low
398
Respiration shoc
Tachypnea, bronchospasm, respiratory failure
399
Renal shock
Receives 20% CO; oliguria associated with vomiting, diarrhea, hemorrhage
400
Heart shock
Pain: decrease coronary perfusion, ischemia, increase LVDP; mental status changes- decrease cerebral perfusion, confused, restless, agitated, delirious, stupor, coma -metabolic: respiratory alk (decrease pco2 breathing fast), followed by met acidosis (Na-(Cl=hCO3); frequently increased lactate-think shock; higher lactate=higher mortality
401
Categories of shock
Hypovolemia shock Distributive shock Cardiogenic shock Extracardiac obstructive shock
402
Hypovolemia shock hemorrhagic
Hemorrhagic: GI bleeding(varice ulcer diverticula), pelvic bleeding (post partum hemorrhage, vaginal hemorrhage), hemorrhagic pancreatitis, AVM
403
Non hemorrhagic hypovolemia shock
GI losses (vomiting diarrhea), skin losses (burns, heart strokes)
404
DKA hypovolemia shock
Renal losses (salt washing, osmotic diuresis) hypoaldosteronism, adrenal insuffiency, third space loss (pancreatitis, bowel obstruction (sequesteration of fluids), systemic inflammation
405
Most common cause of hypovolemia shock
Hemorrhagic shock
406
Treatment issues of volume loss
Depends on the circulating integrity (shock)-over zealous or too rapid correction -rate of replacement composition of replacement
407
Fluid change
If in shock, rx fluids fast-monitor BP and tissue perfusion Crystalloids-Na (main cation) NS useful in hypovolemia from renal, GI, sweat, burns, hemorrhage D5-W equivalent to free water Packed RBC-for hemorrhage function is erythrocytes O2 carriage with delivery
408
Shock class I
Lose 750 ml or up to 15% blood Normal bp Increased pulse pressure Give crystalloid
409
Class II hemorrhagic shock
Lose 750-1500 ml of 15-30% blooc Bp normal Pulse pressure decreased Give crystalloid
410
Class II hemorrhagic shock
Lose 1500-2000 ml blood Decrease bp Decrease pulse pressure Give crystalloid and blood
411
Clas IV hemorrhagic shock
Over 2000 Decreased bp Decreased pulse pressure
412
Distributive shock types
Septic or non septic (vasodilation) Most commoncause of non cardiogenic shock 230000 patients yearly 30-40% mortality
413
Sepsis signs/symptoms
Fever, tachycardia (>90), tachypnea(>20 breaths), increase WBC 12000
414
Common sources of infection distributive shock
Pulmonary-pneumonia, emphysema Ab-peritonitis, cholangitis GU-pyelonephritis, abscess CNS-meningitis Skin-cellulitis, necrotizing fasciitis
415
Septic shock
Severe sepsis and dysfunction of organ systems (decrease O2, decrease UO, increase lactate, decrease platelets, decrease sensorium) -decrease BP <90 for systolic or >40 despite fluids
416
Pathophysiology distributive shock
Tissue hypoxia activates inflammation Endothelial injury-release NO potent vasodilator Mediators of sepsis-endotoxin - cytokines (IL6, TNFa) - NO Microorganisms activate innate, adaptive, and endothelial immune responses and coagulation Endothelial injury-becomes permeable to leak fluids into tissue (lung, intestine, capillary leak) release NO2, potent vasodilator decrease preload Distributive-abnormal distribution of systemic blood flow In addition to vasodilation/microvascular vasoconstrictive tissue hypoxia->increase lactate
417
Signs and symptoms of distributive shock
Extremities/skin-warm flushed(vasodilation) HR fast, 10-30% have myocardial depression BP low <90 for systolic Neck veins flat Mental status changes Renal Hypovolemia, vasodilation, impaired tissue O2 use dissociative shock
418
Vasodilators effects of septic shock
Decrease BP, decrease JVP, creased CVP, decrease SVR Increase HR, N decrease CO increase, PAP-N, N, or decrease in PCWP POAP-pulmonary artery occlusive pressure Extremities-warm, CI>4.2 ``` Lungs-dry Tissue perfusion(mixed venous SVO2 oxyhemoglobin sat)>65% ```
419
Anaphylactic shock diagnosis
CLINCIALLY Signs and symptoms are cutaneous (urticaria, oral facial angioedema, hives, flushing, pruritus), respiratory (dyspnea, cough, wheezing, strider), abdominal (cramping pain), vascular (decrease BP, chest pain and arrhthmias)
420
Life threatening/danger signals of anaphylactic shock
Rapid progression of symptoms
421
Respiratory distress of anaphylactic shock
Strider, persistent cough, wheezing, hypotension
422
Pathophysiology anaphylactic shock
Type I IGE mediated hypersensitivity reaction allergens activate mast cells to release mediators (cytokines, histamine, tryptase) that causes vasodilation, vascular permeability, visceral smooth muscle contraction, tissue inflammation Allergens : drugs, insect bite, foos, latex
423
Distributive hemodynamic profile of anaphylactic shock
PCWP (PAOP) N(early or decrease late CO decrease or increase SVR decrease Tissue perfusion (mixed venous oxyhemoglobin sate) >65%
424
Cardiogenic shock
Decrease in systemic oxygen delivery (DO2) caused by deterioration of cardiac function due to myocardial, valvular, structural, toxic or infectious causes Inadequate cardiac pumping leads to: - decrease BP(<90 or >30 mmHg below baseline) - decrease CO leads to decrease UO (<20 cc/hr) - MSDs(multisystem disorder) - peripheral vasoconstriction
425
Cardiogenic shock definition
CI<22 L/min/m2 Increase PCWP Decrease EF Increase PCWP (PAOP0.18 mmHg SVR (to compensate for decreased BP Decreased tissue perfusion-mixed venous oxyhemoglobin <65%
426
Types of cardiogenic shock
Cardiomyopathies Arrhythmogenic Mechanical
427
Cardiomyopathic cardiogenic shock
MI(>40% LV or extensive ischemia) severe RVMI, stunned myocardium, severe septic shock (depressed EF), myocarditis, cardiomyopathy-exacerbation of severe HF
428
Arrhythmogenic cardiogenic shock
Tach ( a fib, a flutter , re entrant tach), VT, VF | -Brady: complete heart block, mobitz II)
429
Mechanical cardiogenic shock
Severe AI or MR; acute valvular rupture (papillary or chordate tendinae rupture , abscess); critical AS, VSD, ruptured vent wall aneurysm, atrial myxoma
430
Diagnose cardiogenic shock
Decrease BP, decrease UO, mental status changes Cool, mottled extremities Distended neck veins Pul edema Document myocardial dysfunction-echocardiogram-cath
431
Etiology cardiogenic shock
Most common-LV failure due to AMI. Other causes of CS are Acute MR - papillary muscle dysfunction/rupture - chordate tendinae rupture - seen in inferior/posterior MI VSD - ruptures IVS (L to R) - seen in anterior MI RV infarction (RV shock) Vent wall rupture (tamponade)
432
Pathophysiology cardiogenic shock
Failure to pump-decrease myocardial contractility, decrease CO-tissue hypoperfusion, decrease coronary perfusion-pul congestion-pul edema 9increase PCWP-PAOP_ Decrease SV and CI-decrease BO, decrease pO2, incrase alctate, myocardial depression, compensatory vasoconstriction, increase SVR-cool extremities; systemic inflammatory state similar to sepsis AMI associated with increased cytokines-NOW-increase NO-vasodilation-decrease coronary perfusion-incrase ischemia-further myocardial dysfunction
433
Comments on cardiogenic shock
Mortality CS approximately 40-50% Average time to develop CS is 7-10 hours after STEMI CS due to LAD often associated with anterior wall STEMI CS associate with inferior wall STEMI often associated with mechanical complications RV infarction - associated with inferior MI - elevated st segments V4R - distended neck veins, clear lungs, decrease BP - RX -IV fluids (preload sensitive)
434
Treat
Cardiac cath If left main or triple vessel disease, consider surgery If no cath lab, give thrombolytic therapy and transfer to tertiary facility If patients does not want to transfer to another hospital, begin thrombolytic therapy if no contraindication AMI reperfusion
435
Treat STEMI
``` PCI-preferred CABG Fibrinolytic ASA Heparin NSTEMI-glycoprotein IIb/IIIa inhibitors P-pressers-norepinephrine -CS inotropy ```
436
Mechanical support
IABD LVAD ECMO
437
IABD
Decreases afterload, deflated during systole; inflates during diastole-coronary perfusion use for mechanical complication
438
LVAD
Bridge for transplant, tandem heart/impels
439
ECMO
When O2 is severely impaired
440
Arginase
Inhibitor enzyme for endothelial NOS; ROSC-restore spontaneous circulation; EECP-early enhanced contour pulsation
441
Pressure
Norepi Dopamine Inotropy s
442
Norepi
Preferred-alpha I, B1 B2 agonist Vasopressin-vasoconstrictor/use in vasodilators shock
443
Dopamine
Alpha B1 agonist High dose vasoconstrictor-alpha stimulation+inotrope low dose 2 microg/kr vasodilator; phenylephrine peripheral alpha antagonist
444
Inotropes
Dobutamine-B1 agonist; peripheral alpha 1 and b2 agonist. Can vasodilator used with norepi Milrinone-phosphodiesterases inhibit prevents degradation of cAMP. Increase HR, SV and CO
445
Treat RV infarct
Fluids for high filling pressure
446
PAC
Useful when despite adequate fluids given, but not favored
447
Indices of tissue perfusion
Goal increase BP, increase UO, incrase mental status, incrase skin color
448
What avoid
NTG or nitroprusside bc decrease BP=vasodilators-decrease preload, decrease afterload
449
Oasis
Blocks Na K CL transport and increase urinary excretion of Na and Cl to decrease pul edema
450
Acute obstruction to flow in circulation
Extracardiac obstructive shock -obstruction of RV output (massive PE air embolus) impaired diastolic filling of RV (SVC syndrome); cardiac tamponade; constrictive pericarditis; severe hypertension
451
Pulmonary vascular extracardiac obstructive chock
Hemodynamically significant , pulmonary embolus, severe pulmonary HTN, severe or acute obstruction of pulmonary or tricuspid valve
452
Mechanical extracardiac obstructed shock
Tension pneumothorax (trauma, ventilator induces, iatrogenic), pericardial tamponade, constrictive pericarditis, restrictive cardiomyopathy
453
Extra obstructive cardiac shock pearls
Pleuritic chest pain and dyspnea-PE Chronic dyspnea, increased P2=PHT Chest pain, tracheal deviation (away from affected side), decreased unilateral breath sounds-tension pneumothorax Distended neck veins, muffles heart sounds, pulsus paradoxus dilated IVC=cardiac tamponade Equalization of pressures (RA, RVEDP, PCWPP)=think tamponade, constrictive pericardial disease, restrictive cardiomyopathy0
454
Presentation extracardiac obstructive shock tension pneumothorax
SOB, unilateral pleuritic chest pain and decreased breath sounds, neck vein distention TRACHEAL DEVIATION AWAY FROM AFFECTED SIDE
455
RX extracardiogenic tension pneumothorax
IV catheter in 2nd, 3rd ICS, MCL followed by chest tube or emergent tube thoracotomy in 5th
456
Pericardial tamponade signs
Dyspnea, tachycardia, decrease BP, increase JVD< muffles heart, pulsus paradoxus, ECG, electrical alternana
457
Echo pericardial tamponade
RA collapse (highly sensitive sign; RV collapse; IVC dilation
458
RX pericardial tamp
Echo/US to guide pericardialcentesis
459
Symptoms of hemodynamically significant pulmonary embolus
Dyspnea, hypoxia, hypotension (sudden), tachypnea, tachycardia, cough, pleuritic chest pain, syncope, sudden death
460
Risk factors for hemodynamically significant pulmonary embolus
VTE in leges, pelvis, arms-most common, Non thrombotic material (fat, air , tumor cells, amniotic cancer, hypercoagulabiltiy (factor V ) previous VTE?PE, pregnancy
461
Pathophysiology hemodynamically significant pulmonary embolus
Clots embolize; large clot may lodge in main PA or branches, smaller clots peripherally; may cause PE infarction; vent> perfusion (V/Q mismatch) increase pul vascular resistance, incrase PASBP, increase RV afterload, increase RVEDP, increase RAP increase TR
462
PE hemodynamicaly significant pulmonary embolus
Increase JVD, increase P2 or widely split P2-due to delayed emptying of RV R>20/min, increase HR
463
Obstructive hemodynamic profile
Decrease Increase HR Increase JVD Extremities cool Lungs dry Co-N decrease PCWP PAOP N or decrease SVR increase
464
CTPA imaging
Computer tomography pulmonary angiography Permits visualization of thrombi in pul arteries Preferred over ventilationperfusion lung V/Q
465
V/Q scan
Used if Agilent is allergic to contrast agents (used for CTPA), renal insuffiency , women <40 yo decreased radiation and preg
466
D dimer
Degradation product of fibrin; indirect index of clotting. High sensitivity , low specificity. If negative, PE not likely diagnosis. Venous Doppler of legs/pelvis /arms-looking for VTE
467
ECG
S1 Q3 T3
468
Echocardiogram
RV dilation, TR
469
hemodynamically significant pulmonary embolus BNP and trop
BNP and troponin elevated
470
CXR pulmonary embolism
Atelectasis RLL, otherwise normal
471
ECG pulmonary embolism
Sinus tach, incomplete RBBB, PAC, st changes
472
ABG pulmonary embolism
PH 7.5 pCO2 29, PO2 58 HCO3 26
473
CBC CMP pulmonary embolism
Normal
474
Venous Doppler
R leg DVT femoral vein
475
CTPA pulmonary embolism
Large thrombus in PA
476
D dimer pulmonary embolism
Positive
477
Echo pulmonary embolism
Normal
478
Heart failure
Inability of the heart to meet the metabolic demands of the body
479
What percent of adults will develop HF
10, 10% of people over 53 have this
480
Mortality rate HF
1 year 10-20% 5 year 50%
481
Etiology HF
60-75% CAD-ISD 18% idiopathic 12% valvular 10% hypertensive *most common cause of LV systolic dysfunction is from ischemic heart disease
482
Basic cause of HF
Restriction/obstruction to ventricular filling - RV infarct - constrictive pericarditis - MS - atrial myxoma
483
State A HF
HF risk factors no heart disease no symtpoms
484
Stage B HF
Heart disease no symptoms Asymptomatic LV dysfunction
485
State C HF
Prior or current HF symptoms
486
Stage C heart failrue
Refractory symptoms
487
Stage A ACC/AHA
CAD (ischemis, atherosclerotic), HT, DM< obesity, metabolic syndrome, excess alcohol; who do not demonstrate structural heart disease or symptoms. One year mortality (about 5-10% using cardiotoxins/family history of cardiomyopathy) (associated with any existing co-morbid conditions)
488
Stage B ACC/AHA
Asymptomatic patients has LVH and/or impaired LV function (low EF) previous MI, valvular disease, structural heart disease; hemodynamically stable. One year mortality 50%
489
Stage C ACC?AHA
Patient with current or past symtpoms of HF with structural heart disease; SOB , fatigue, reduced exercise tolerance; one year mortality 15-30%
490
Stage D ACC AHA stages
Refractory HFl eligible for specialized treatment (mechanical support , transplants) one years mortality 50-60%
491
Class I NYHA
No limitation of physical activity No symptoms. With ordinary exertion One year mortality 5-10% Asymptomatic
492
Class II NYHA
Slight limitation on physical activity Ordinary activity causes symtpoms One year mortality 15-30% No rest sx Exertional sx with ordainary activity
493
Class III NYHA
Marked limitation of physical activity Less that ordinary activity causes symptoms Asymptomatic at rest One year mortality 15-30% No rest sx Sx with minimal activity
494
Class IV NYHA
Inability to carry out physical activity without discomfort Symptoms at rest One year mortality 50-60% Rest sx
495
Pathogenesis of HF
Impaired systolic function Impaired diastolic function Mechanical abnormalities Disorders of rate/rhythm Pulmonary heart disease High output states
496
Echo can see what specific causes of heart failrue
``` Hypertensive heart disease Ischemic heart disease Hypertrophic heart disease Infiltrating heart disease Primary valvular heart disease ```
497
What is echo necessary to distinguish
Necessary to distinguish systolic heart failure from diastolic heart failrue
498
Types of heart failure
Systolic/diastolic High/low Acute/chronic Right/left Forward/backward
499
Acute HF
Heart failure due to acute MI, ruptured papillary msucle , MR, AI, toxins
500
Chronic HF
Multivalvular disease of dilated cardiomyopathy Progresses slow Edema, weight gain
501
Systolic HF (HFrEF-reduced)
At least 50% of cases: decrease SV, increase vent filling pressure EF less than 40%, hypoperfuion with impaired ventricular emptying Weak, fatigues, reduced exercise tolerance DOE, orthopnea, PND LVEF=SV/EDV Associated with CAD, VHD, HT, myocarditis
502
Diastolic HF-normal EF (HFpEF-preserved)
SOB, DOE, pulmonary edema Inability of LV to relax/fill; increased resistance to vent filling; decreased compliance or increased stiffness Decreased vent diastolic capacity to relax Ex. Restrictive/constrictive pericarditis, HTN, hypertrophic, cardiomyopathy Impaired vent relax- - acute ischemia - myocardial fibrosis - amyloidosis Associated with HT, obesity, DM, CAD< aging
503
High output
Hyperthyroidism, anemia, pregnancy, AV fistula, beriberi, paget High CO but low EF
504
Low output
Ischemic heart disease, HTN | -dilated cardiomyopathy, valvular and pericardial disease
505
Right sided HF
Affects RV Pulmonary HTN due to pulmonary embolus Edema, hepatomegalia, venous distention
506
Left sided HF
LV is overloaded AS, MI Dyspnea, orthopnea, due to pul congestion
507
Neurohormonal compensation response of HF
``` SNS RAAS Cytokines activation Altered renal physiology LV remodeling ```
508
RAAS
Decreased renal perfusion Increased renin, angiotensinogen, A1 A1 ACE increases BP by vasoconstriction; stimulates adrenal gland release aldosterone . Na and H2O retention (increase preload, congestive symtpoms and volume expansion) A11-vasoconstrictor increases PVR (increase afterload
509
Arginine vasopressin
AVP or ADH | -stimulation of thirst leads to increase TBW and hyponatremia (dilutional). Increases preload (salt and water retention)
510
Precipitating causes of HF
Sometimes decompensation of HF relates to underlying progression of heart disease Non compliance with diet - too much Na - too many calories - too many stimulants Non compliance with meds - too costly - side effects Medes that worsen HF-CCB, BB, NSAIDS< antiarrhythmias Infection Anemia - increased oxygen needs of tissues - increased CO Thyrotoxicosis/pregnancy -high CO state Arrhythmias - tachyarrhythmias-decrease diastolic filling time, leading to ischemia - bradycardia
511
Signs and symptoms of HF
Decreased arterial perfusion to organs and venous congestion leads to dyspnea-most common Exercise intolerance, orthopnea, PND< nocturnal angina-due to pul congestion and increased LA pressure PND increases the likelihood of HF Weakness, fatigue not specific Pulmonary edema-crackles , transsudation of fluid from pulmonary capillaries into alveolar spaces and interstitium. Wheeze, frothy pink fluid, possible cyanosis and acidosis Hepatomegalia-passive congestion with increased LFT altered coagulation studies, ascites, increased abdominal girth, peripheral and sacral edema JVD-CVP can be elevated in volume overload; prominent in cardiac tamponade and COPD
512
Heart and HF
S3 gallop increases likely hood of HF 11 fold S4 LV failure Orthopnea, PND Tachypnea, wheezing, crackles, decreased breath sounds Dullness to percussion over pleural effusions
513
RV failrue
Peripheral/sacral edema Hepatomegalia Ascites Increased JVD, HJR
514
Where is the JVD Seen
As crosses the sternocleidomastoid muscle into the posterior triangle of the neck and disappears beneath the clavicle to join the brachiocephalic vein
515
How measure JVD
Raise head slightly of f pillow to relax sternocleidomastoid Raise the head of bed 30 degrees turn head slightly away fromt he side you are inspecting Use tangential lighting and examine both sides of the neck. Find internal jugular venous pulsation If necessary, raise or lower head of bed till see oscillation point of internal jugular venous pulsation in the lower half Focus on right internal jugular vein. Look for pulsation int he suprasternal notch, between the attachments of the sternomastoid muscle on the sternum and clavicle or just posterior to sternomastoic Identify highest point of pulsation in the right jugular vein-extend a long rectangular object or card horizontally from this point and a centimeter ruler vertically from the sternal angle, making an exact right angle. Measure the vertical distance in centimeters above the sternal angle where the horizontal object crosses the ruler and add to this distance 4 cm,
516
What is a venous pressure above normal
At >3m above the sternal angle, or more than 8 cm or 9 cm in total distance above the right atrium
517
Diagnostic test for HF
No single diagnostic test for HF; it is largely a clinical diagnosis checked on a careful HP
518
CXR HF
Cardiomegalia Pulmonary edema with central peripheral infiltrates Increased size of vessels in upper portion of lungs Pleural effusions
519
Echo HF
Practical useful, mobile, bedside/ICU/ED Chamber size, clots, tumors Wall motion muscle thickness Pericardial effusions Valvular disease Systolic.diastolic HF-ejection fraction
520
ECG HF
May have ischemia, infarction, hypertrophy Rhythm disturbances (atrial, junctional, ventricular ) Tachycardia/bradycardia/blocks
521
Troponin T and I
Released from myocytes when damaged - increase 3-12 hours from onset of chest pain - peak 24-48 hours; return to baseline 5-14 days
522
CK-MB
Increases 3-12 hours from onset of chest pain Peak 24 hours; baseline 1-3 days Sensitivity
523
CBC HF
Anemia secondary to chronic disease Anemia may aggravate HF
524
CMP HF
Electrolyte imbalance-low Na, K | Pre renal azotemia-high BUN to creatine
525
UA HF
Protein in urine
526
Thyroid labs HF
If patient is in HF, greater that 65 years old with a fib, check the thyroid Free t4, TSH ABG-may have hypoxia, metabolic acidosis from lactic acidosis
527
BNP
Brain natiuretic peptide Neurohormonal, made in ventricles Sensitive to ventricle stretching and volume overload. Preload/afterload are stimuli Lower EF, high BNP If value is less than 100pg/ml, there is a 97% chance of no HF Increased BNP in heart failure, AMI, PE, renal failure, old age
528
Differential diagnosis of HF
Pulmonary problems - PE - asthma - pneumonia Cirrhosis - ascites - edema Renal-edema Venous insuffiency-edema
529
Five basic principles of HF
Make correct diagnosis-exclude mimics of HF Determine etiology of heart disease Determine precipitating factors Understand pathophysiology of HF Understand mechanism of action of pharmacological therapy
530
Indications for admission to hospital for management of HF
``` Acute MI Severe respiratory distress Hypoxia Hypotension Cardiogenic shock Anascara Syncope Heart failure refractory to oral medications ```
531
Non pharm treatment of HF
Quit smoking Lower weight AHA diet, 2 gram Na diet Fluid restriction <2 L a day Avoid isometric activity-increase SVR and afterload Encourage isotonic activity-walking, hiking, golf Stool softened Subcut levenox Oxygen Avoid alcohol Treat HTN, hyperlipidemia, diabetes
532
How counsel patient HF before discharge of hospital
Diet-patient with spouse/other sodium restriction, Carl our restriction if overweight stimulants Education Rehab exercise Medes: ACE/ARB, bb, ASA, statin, nitro prn
533
CO
SVxHR
534
Stoke volume is modulated by what
Preload Afterload Contractility
535
Conventional treatments of HF
Diuretics -reduce fluid volume Vasodilators -decrease preload and/or afterload Inotropes -augment contractility
536
Class I
Evidence and/or agreement that therapy/procedure is beneficial, useful and/or effective; beneficial, useful and/or effective; benefit 3+ risk
537
Class II
Conflicting evidence and/or divergence of opinion IIa-weight of evidence .opinion infavor -benefit 2+ risk IIb-less established evidence/opinion-benefit 1+ risk
538
Class III
Evidence and/or agreement that therapy/procedure is not effective; may be harmful -no benefit
539
A level evidence
Data from meta analysis or multiple randomized clinical trials; multiple populations evaluated
540
B level evidence
Data from single randomized trial or non randomized studies; limited population evaluated
541
Level C evidence
Only consensus opinion of experts , case studies, or standard of care, very limited populations
542
Pharm treatment of HF
ACE I or ARB BB Diuretic Spironolactone Digitalis IV inotropes Hydralazine Nitrates CCB Sacubitril-Vallarta’s ivabradine
543
ACE I
Block conversion of angiotensin I to angiotensin II -useful for all NYHA functional classifications with systolic heart failrue Lower mortality and morbidity by 20% supported by several good drug trials Useful in preventing HF in high risk patients (ASHD, MI, HT) level of evidence A Recommended in patients with symptoms of HF, reduced EF, unless contraindicated: L or E: A
544
When use ACE cautiously
Use cautiously with renal insuffiency or K greater than 5 mEq/l
545
Contraindication ACE I
Angioedema | Pregnancy
546
AE ACE I
Bilateral RAS(renal artery stenosis) Cough
547
List ACE I
``` Lisinopril Enalapril Captopril Benazepril Ramipril Quinapril ```
548
ARB
Block AT1 and AT2 receptor for angioteensin Blocker A11 at receptor without inhibiting kininase Don’t get cough that is due to accumulation of kinins
549
ACE
Block angiotensin I to angiotensin II Improve LV relax and contraction Veno and vasodilation
550
ARB action
Increases myocardial fibrosis Increases NE Increases vasoconstriction Increases endothelin1
551
Why get cough from ACE
Bradykinin accumulated
552
ARB vs ACE
Comparable but neither more effective Don’t give ARB to patient that got angioedema from ACE
553
Name ARBS
``` Losartan Vallarta’s Candesartan Telmisartan Irbesartan Entresto; sacubitril is the neprilysin inhibitor and Vallarta’s is AII receptor blocker ```
554
BB
Survival benefit in chronic syst HF and dilated cardiomyopathy Slow progression of disease and decrease hospitalization Improve cardiac performance and symptoms of HF
555
Hemodynamics of BB
Decrease heart rate Antiarrhythmic properties Antiischemic Blunts SNS effects of NE Reverse remodeling
556
BB good
Clinical trials reveal decrease mortality -CIBIS II US carvedilol HF program - improve LVEF and well being - Corey, alpha1, beta1, beta2 receptor, with vasodilator property and antioxidant
557
Who don’t give BB
Unstable class IV
558
Who give BB
All stable patients with symptoms of HF, reduced EF, unless contraindicated. Level of evidence: A Patients with class II and II NYHA
559
Diuretics for HF
Relieve congestion(pulmonary) symtpoms by reducing preload Increase cardiac function Promote natiuretic, urinalysis Na excretion Inhibits NaCl resorption from AL or LOH Increase risk of arrhythmia deaths without K sparing
560
AL or LOH diuretics
Lasix (furosemide) Bumex (bumetanide) Demanded (torsemide)
561
DT
Thiazide Zaroxolyn (metolazone)
562
Late DT
Spironolactone (aldactone)
563
How give furosemide
10 mg IV.he or 40 mg IV every 8-12 hours Watch K Mg, Na, BUN, creatinine
564
Digitalis
Inotropes agent DIG Improves the quality of life associated with HF but no demonstrable effect on survival Useful in HFrEF and a fib for ventricular rate control
565
Why use digitalis
HFrEF and a fib for ventricular rate control
566
MOA digitalis
Inhibits Na/K/ATPase; affect to increase contractile state by increasing intracellular calcium conc. Useful in atrial fibrillation to slow ventricular rate
567
Spironolactone
Antagonizes effects of aldosterone Use in addition to standard care (ACE, BB, diuretic, dig)
568
RALES
``` Randomized aldactone evil study (aldactone-spironolactone) 12.5-25 mg/day; class III-IV patients -30% reduction in mortality ```
569
How watch spironolactone
Watch K closely if GFR is less than 30 cc/min or creatinine is greater than 1.6 mg/dl
570
Level of evidence of spironolactone
B-decreased mortality, decreased HF hospitalization s
571
Eplerenone
New watch K
572
Inotropes
Increases contractility Dobutamine -stimulating beta1 and beta2 receptors Milrinone - inotropic vasodilator - inhibits phosphodiesterase
573
Dopamine
Stimulates beta 1 receptor 2-10 ug/kg/min Higher doses stimulate alpha receptors Useful short term
574
Hydralazine plus isosorbide dinitrate
Hydralazine -arterial vasodilator, reduces afterload and SVR Nitrates -vasodilator to reduce preload or reduce venous return to increase CO When H+ N are added to diuretics and dig, may: Reduce mortality Increase EF Increase exercise tolerance
575
Isosorbide dinitrate | Isosorbide mononitrate
Better response to hydralazine and isosorbide in african Americans that in whites; use if intolerant to ACE/ARB Nitroprusside Vasodilator monitor BP closely
576
Nitrates hemodynamic effects
1. Venous vasodilation Decrease preload leads to pulmonary congestion, decrease ventricular size, decrease vent wall stress, decrease MVO 2. Coronary vasodilation - increase myocardial perfusion 3. Arterial vasodilation - decrease afterload leads to decreased CO, BP
577
CCB
Class III No benefit Not recommended as routine Treatment for patients with HF associated with reduced ejection fraction
578
Role of OMM if HF lymph treatment
Open thoracic inlet to decrease flow fascial restriction, to allow between lymphatic flow in thoracic duct - if blocked, will not have optimal fluid drainage. - always do this before and after lymph treatment so moblized fluids has a place in drain. Rib raising-dec. hyperactive sympathetic tone -helps open chest cage for more optimal breathing effort, rib excursion. Mobilizes fluid Diaphragm abd doming -as effective as LE exercise for fluid movement
579
Effleuragepetrissage-distal to proximal stroking of extremities
Can reduce edema of extremities by helping move fluid centrally Cervical stroking (opposite of myofascial release, push toward chest from head Open thoracic duct again Ensure fluid has a place to drain
580
Conclusion HF
Make the right diagnosis Look for the precipitating causes and underlying etiology Provide treatment based on solid evidence based recommendations.